Skip to content
    Drishti.money
    Earnings calls

    Archean Chemical concall ledger

    Every earnings call for ACI — management tone, guidance, KPIs and promise tracking, quarter by quarter.

    ACI · 6 transcripts · Chemicals · latest Q4 FY26
    Q4 FY26Published 13 May 2026Call held 13 May 2026

    ACI Q4 FY26 Earnings Call Transcript & Analysis

    Total Revenue₹1,088.8 cr+2% YoYEBITDA₹66.4 cr−34% YoYEBITDA Margin21.79%PAT₹29.8 crTotal Income₹304.7 cr−9% YoY

    Total Revenue (Standalone FY26) ₹1,089 cr (+2% YoY); EBITDA (Standalone) ₹66 cr (−34% YoY); EBITDA Margin (Standalone) 21.79%. FY26 Total Revenue grew 2% YoY to INR 1,088.8 crores (standalone).

    Read full transcript & analysis
    Q3 FY26Published 06 Feb 2026Call held 06 Feb 2026

    ACI Q3 FY26 Earnings Call Transcript & Analysis

    Standalone Total Revenue7,840 million+7% YoYStandalone EBITDA698.6 million−27% YoYStandalone EBITDA Margin27%Standalone Net Profit343 millionStandalone Total Income2,608.1 million+2% YoY

    Standalone Total Revenue (9M FY26) 7840.0 million (+7% YoY); Standalone EBITDA (Q3 FY26) 698.6 million (−27% YoY); Standalone EBITDA Margin (Q3 FY26) 27.0%. Q3 FY26 standalone total income grew 2.4% YoY to INR 2,608.1 million.

    Read full transcript & analysis
    Q2 FY26Published 18 Nov 2025Call held 18 Nov 2025

    ACI Q2 FY26 Earnings Call Transcript & Analysis

    Standalone Revenue2,317.8 million−8% YoYStandalone EBITDA759.9 million−15% YoYStandalone EBITDA Margin33%Standalone Net Profit384.6 million

    Standalone Revenue (Q2 FY26) 2317.8 million (−8% YoY); Standalone EBITDA (Q2 FY26) 759.9 million (−15% YoY); Standalone EBITDA Margin (Q2 FY26) 33.0%. H1 FY26 standalone revenue grew 10% to INR 5,232.3 million.

    Read full transcript & analysis
    Q1 FY26Published 31 Jul 2025Call held 31 Jul 2025

    ACI Q1 FY26 Earnings Call Transcript & Analysis

    Consolidated Revenue₹300.59 cr+30% YoYConsolidated EBITDA₹86.32 crConsolidated EBITDA Margin28.72%Consolidated Net Profit₹40.14 cr

    Consolidated Revenue ₹301 cr (+30% YoY); Consolidated EBITDA ₹86 cr; Consolidated EBITDA Margin 28.72%. Consolidated Revenue of ₹300.59 crores, up 30% YoY.

    Read full transcript & analysis